WEARABLE HEALTHCARE TECHNOLOGY – THE REGULATORY PERSPECTIVE
Journal Title: International Journal of Drug Regulatory Affairs - Year 2016, Vol 4, Issue 1
Abstract
The world today isn’t the one which it was yesterday. With the continuing evolution in technology and technological applications on medical field, innovative products and services have been emerging every day. Wearable gadgets have risen up as revolution in the medical field for patient care. A number of tech giants are pouring into this segment; wearables have already shown an impact on various fields such as communication and navigation; but perhaps the greatest potential lies in healthcare. With this article, an attempt has been made to unlock the potential of wearable healthcare technology and the regulatory aspects imparted on them currently.
Authors and Affiliations
Akshay Anand M, Venkatesh M P, Pramod Kumar T M
Keywords
Related Articles
- EP ID EP337041
- DOI -
- Views 114
- Downloads 0
Integrating PLCM strategy in Pharmaceutical Emerging Market
All products and services must denote definite life cycles. The life cycle talks about the period from the product‘s first launch till it wind-up onto the market. Throughout this age noteworthy modifications are made in...
REGULATORY REQUIREMENTS FOR DRUG PRODUCTS REGISTRATION IN SOUTH AFRICA
The South African Pharmaceutical market is one of the emerging markets in the world and it is important to study on how to register a drug in the promising pharmaceutical market in Africa. The MCC is the regulatory body...
AN OVERVIEW OF CHINESE DRUG REGULATORY SYSTEM: A REVIEW
The Drug regulatory authority of China was renewed from state pharmaceutical administration of China (SPAC) to state food and Drug administration (SFDA) with the announcement and declaration of Chinese ministry of health...
FORMULATION, DEVELOPMENT AND OPTIMIZATION OF MODIFIED RELEASING PELLETS OF DRUG CARVEDILOL
The main objectives of present work was to design and evaluate modified releasing pellets of drug, Carvedilol, in respect to increase patient compliance and therapeutically benefits. The modified releasing pellets were m...
Preliminary requirement for ANDA Filing
USFDA is very critical regulated agency for submission. This review reveals how to submit an Abbreviated New Drug Application (ANDA) as per FDA under section 505(j) of the Federal Food, Drug, and Cosmetic Act (FD&C Act)...